Can you provide the last earnings date for KRYSTAL BIOTECH INC?
KRYSTAL BIOTECH INC (KRYS) last reported earnings on 2/17/2026.
KRYSTAL BIOTECH INC (KRYS) Earnings History & Surprises
NASDAQ:KRYS • US5011471027
Current stock price
245.39 USD
-6.01 (-2.39%)
At close:
245.39 USD
0 (0%)
After Hours:
KRYS Earnings overview
Past quarterly earnings results for KRYSTAL BIOTECH INC (KRYS), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $1.37
- Revenue Estimate
- 113.8M
Last Reported
Most Recent- Release Date
- Feb 17, 2026
- Period
- Q4 / 2025
- EPS Reported
- $1.70
- EPS Surprise
- 18.32%
- Revenue Surprise
- -0.31%
Beat Rate
Last 8 Quarters 44%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 1.70 | 1.44 | 18.32% | 11.84% | 107.105M | 107.44M | -0.31% | 17.52% |
| Q3 2025 | 2.66 | 1.11 | 140.23% | 192.31% | 97.8M | 95.049M | 2.89% | 16.65% |
| Q2 2025 | 1.29 | 1.15 | 12.14% | 143.40% | 96.042M | 93.77M | 2.42% | 36.65% |
| Q1 2025 | 1.20 | 1.39 | -13.89% | 3,900.00% | 88.183M | 98.167M | -10.17% | 94.88% |
| Q4 2024 | 1.52 | 1.19 | 27.68% | 406.67% | 91.139M | 92.299M | -1.26% | 116.26% |
| Q3 2024 | 0.91 | 0.92 | -0.73% | 231.88% | 83.841M | 84.604M | -0.90% | 879.91% |
| Q2 2024 | 0.53 | 0.59 | -10.41% | 142.40% | 70.284M | 66.642M | 5.47% | - |
| Q1 2024 | 0.03 | 0.15 | -80.01% | 101.70% | 45.25M | 48.368M | -6.45% | - |
| Q4 2023 | 0.30 | -0.43 | 169.20% | 124.00% | 42.143M | 29.179M | 44.43% | - |
| Q3 2023 | -0.69 | -0.29 | -136.53% | 41.03% | 8.556M | 6.447M | 32.71% | - |
| Q2 2023 | -1.25 | -0.75 | -66.36% | -13.64% | - | - | ||
| Q1 2023 | -1.76 | -1.47 | -19.94% | -77.78% | 204K | -100.00% | - | |
| Q4 2022 | -1.25 | -1.35 | 7.28% | -31.58% | - | - | ||
| Q3 2022 | -1.17 | -1.24 | 5.76% | -67.14% | - | - | ||
| Q2 2022 | -1.10 | -1.04 | -6.18% | -48.65% | - | - | ||
| Q1 2022 | -0.99 | -1.07 | 7.44% | -47.76% | - | - | ||
| Q4 2021 | -0.95 | -0.75 | -27.15% | -79.25% | - | - | ||
| Q3 2021 | -0.70 | -0.75 | 7.08% | -42.86% | - | - | ||
| Q2 2021 | -0.74 | -0.77 | 4.23% | -100.00% | - | - | ||
| Q1 2021 | -0.67 | -0.57 | -17.93% | -116.13% | - | - | ||
| Q4 2020 | -0.53 | -0.61 | 12.43% | - | - | - | ||
| Q3 2020 | -0.49 | -0.48 | -2.45% | - | - | - | ||
| Q2 2020 | -0.37 | -0.48 | 22.82% | - | - | - | ||
| Q1 2020 | -0.31 | -0.45 | 31.59% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
39.20%
Max EPS beat (4)
140.23%
Min EPS beat (4)
-13.89%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
-1.29%
Max Revenue beat (4)
2.89%
Min Revenue beat (4)
-10.17%
Analysis
In the last 4 quarters, KRYS has beaten EPS estimates in 3 out of 4 releases
KRYS has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, KRYS has beaten the EPS estimates by 39.2% on average.
In the last 4 quarters, KRYS reported -1.3% below the revenue estimates on average.
Related analysis
KRYSTAL BIOTECH INC / KRYS Earnings FAQ
Did KRYS stock beat earnings estimates in the most recent quarter?
KRYSTAL BIOTECH INC (KRYS) beat EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does KRYS stock beat earnings estimates?
In the last 4 quarters, KRYSTAL BIOTECH INC (KRYS) has beaten EPS estimates in 3 out of 4 releases.